5-FAM-Dyrktide

O=C1OC2(C3=C1C=C(C=C3)C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N4[C@H](C(N[C@H](C(N[C@H](C(N5[C@H](C(N[C@H](C(N[C@H](C(NCC(N6[C@H](C(N7[C@H](C(N[C@H](C(O)=O)CCCCN)=O)CCC7)=O)CCC6)=O)=O)CCCNC(N)=N)=O)CC(C)C)=O)CCC5)=O)CO)=O)C)=O)CCC4)=O)CCCNC(N)=N)=O)CC8=CC=CC=C8)=O)CCCNC(N)=N)=O)CCCNC(N)=N)=O)CCCNC(N)=N)=O)C9=C(C=C(C=C9)O)OC%10=C2C=CC(O)=C%10

[1]S Himpel, et al. Specificity determinants of substrate recognition by the protein kinase DYRK1A. J Biol Chem. 2000 Jan 28;275 (4) :2431-8.|[2]Kevin D Freeman-Cook, et al. Discovery of PF-06873600, a CDK2/4/6 Inhibitor for the Treatment of Cancer. J Med Chem. 2021 Jul 8;64 (13) :9056-9077.